Pierre Fabre, Forest Launch Collaboration | January 5, 2009 Issue - Vol. 87 Issue 1 | Chemical & Engineering News
Volume 87 Issue 1 | p. 14 | Concentrates
Issue Date: January 5, 2009

Pierre Fabre, Forest Launch Collaboration

Department: Business

Pierre Fabre Medicament and Forest Laboratories will collaborate on the development and commercialization of F2695, a small-molecule treatment for depression. Forest will handle clinical development and commercialization of F2695 in the U.S. and Canada, and Pierre Fabre will fund all preclinical development and drug manufacturing worldwide. Forest will pay Pierre Fabre $75 million and make undisclosed milestone payments.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment